Lung cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with early stage lung cancer (T1a-T2aN0M0) or 1-3 metastatic lung cancer who will be treated with dynamic tumor-tracking stereotactic body radiation therapy.
Exclusion criteria
Exclusion criteria: Patients who do not agree with this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility of the dynamic tumor-tracking irradiation based on 4D-CBCT without fiducial marker. | — |
Countries
Japan
Contacts
Kyoto University Graduate School of Medicine Department of Radiation Oncology & Image-applied Therapy